Budget Amount *help |
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2016: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2015: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2014: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2013: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Outline of Final Research Achievements |
Magnolol, a natural PPAR-gamma agonist, enhanced the tumor selective cytotoxic activity of a new sesquiterpene from Santalum album heart wood against HL-60 leukemia cells by more than 100 times. Furthermore, a prenylisoflavonoid derivative from Glycyrrhiza glabra roots and a new coumarin derivative from Angelica dahurica roots exhibited PPAR-gamma agonist activity and attenuated the cytotoxicity of etoposide, a clinically used anticancer agent, against A549 lung adenocarcinoma cells. The kampo prescription of Shimpito Extract and Ephedra Herb extract showed PPAR-gamma agonist activity. Three prenylfuranocoumarin derivatives were isolated from Glehnia littoralis roots and rhizomes as the PPAR-gamma agonists.
|